Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX in Peri-operative Treatment of Liver Metastasis From Colorectal Cancer
NCT00997685Phase 2Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Nov 2009
- Primary completion
- Oct 2015
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in colorectal cancer (CRC), sponsored by Guangdong Provincial People's Hospital. Status: unknown.
02
Drugs
capecitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00997685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00997685.